These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 17303204)

  • 61. Mutations in the carboxyl terminal region of E2 glycoprotein of classical swine fever virus are responsible for viral attenuation in swine.
    Risatti GR; Holinka LG; Fernandez Sainz I; Carrillo C; Kutish GF; Lu Z; Zhu J; Rock DL; Borca MV
    Virology; 2007 Aug; 364(2):371-82. PubMed ID: 17418362
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Phenotypic and molecular characterization of a non-lethal, hamster-viscerotropic strain of yellow fever virus.
    McArthur MA; Xiao SY; Barrett AD
    Virus Res; 2005 Jun; 110(1-2):65-71. PubMed ID: 15845256
    [TBL] [Abstract][Full Text] [Related]  

  • 63. A pyrazolotriazolopyrimidinamine inhibitor of bovine viral diarrhea virus replication that targets the viral RNA-dependent RNA polymerase.
    Paeshuyse J; Letellier C; Froeyen M; Dutartre H; Vrancken R; Canard B; De Clercq E; Gueiffier A; Teulade JC; Herdewijn P; Puerstinger G; Koenen F; Kerkhofs P; Baraldi PG; Neyts J
    Antiviral Res; 2009 Jun; 82(3):141-7. PubMed ID: 19428605
    [TBL] [Abstract][Full Text] [Related]  

  • 64. In vitro potency assay for yellow fever vaccines: comparison of three vero cell lines sources.
    Fournier-Caruana J; Poirier B; Garnier F; Fuchs F
    Biologicals; 2000 Mar; 28(1):33-40. PubMed ID: 10799054
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Expression of foreign protein epitopes at the surface of recombinant yellow fever 17D viruses based on three-dimensional modeling of its envelope protein.
    Bonaldo MC; Garratt RC; Freire MS; Galler R
    Cell Biochem Biophys; 2006; 44(3):313-24. PubMed ID: 16679518
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Inhibition of Japanese encephalitis virus replication by peptide nucleic acids targeting cis-acting elements on the plus- and minus-strands of viral RNA.
    Yoo JS; Kim CM; Kim JH; Kim JY; Oh JW
    Antiviral Res; 2009 Jun; 82(3):122-33. PubMed ID: 19428603
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Effect of genomic variation in the challenge virus on the neutralization titres of recipients of inactivated JE vaccines--report of a collaborative study on PRNT50 assays for Japanese encephalitis virus (JE) antibodies.
    Ferguson M; Johnes S; Li L; Heath A; Barrett A
    Biologicals; 2008 Mar; 36(2):111-6. PubMed ID: 17892945
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Fusogenic peptide as diagnostic marker for detection of flaviviruses.
    Pattnaik P; Srivastava A; Abhyankar A; Dash PK; Parida MM; Lakshmana Rao PV
    J Postgrad Med; 2006; 52(3):174-8. PubMed ID: 16855316
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Neuroadapted yellow fever virus 17D: determinants in the envelope protein govern neuroinvasiveness for SCID mice.
    Nickells M; Chambers TJ
    J Virol; 2003 Nov; 77(22):12232-42. PubMed ID: 14581560
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Efficacy, duration, and onset of immunogenicity of a West Nile virus vaccine, live Flavivirus chimera, in horses with a clinical disease challenge model.
    Long MT; Gibbs EP; Mellencamp MW; Bowen RA; Seino KK; Zhang S; Beachboard SE; Humphrey PP
    Equine Vet J; 2007 Nov; 39(6):491-7. PubMed ID: 18065305
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Safety evaluation of chimeric Langat/Dengue 4 flavivirus, a live vaccine candidate against tick-borne encephalitis.
    Pripuzova NS; Tereshkina NV; Gmyl LV; Dzhivanyan TI; Rumyantsev AA; Romanova LIu; Mustafina AN; Lashkevich VA; Karganova GG
    J Med Virol; 2009 Oct; 81(10):1777-85. PubMed ID: 19697399
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Antibodies targeting linear determinants of the envelope protein protect mice against West Nile virus.
    Ledizet M; Kar K; Foellmer HG; Bonafé N; Anthony KG; Gould LH; Bushmich SL; Fikrig E; Koski RA
    J Infect Dis; 2007 Dec; 196(12):1741-8. PubMed ID: 18190253
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Antiviral activity of lauryl gallate against animal viruses.
    Hurtado C; Bustos MJ; Sabina P; Nogal ML; Granja AG; González ME; Gónzalez-Porqué P; Revilla Y; Carrascosa AL
    Antivir Ther; 2008; 13(7):909-17. PubMed ID: 19043925
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Exchanging the yellow fever virus envelope proteins with Modoc virus prM and E proteins results in a chimeric virus that is neuroinvasive in SCID mice.
    Charlier N; Molenkamp R; Leyssen P; Paeshuyse J; Drosten C; Panning M; De Clercq E; Bredenbeek PJ; Neyts J
    J Virol; 2004 Jul; 78(14):7418-26. PubMed ID: 15220415
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Thiosemicarbazones and Phthalyl-Thiazoles compounds exert antiviral activity against yellow fever virus and Saint Louis encephalitis virus.
    Pacca CC; Marques RE; Espindola JWP; Filho GBOO; Leite ACL; Teixeira MM; Nogueira ML
    Biomed Pharmacother; 2017 Mar; 87():381-387. PubMed ID: 28068627
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Safety and efficacy in geese of a PER.C6-based inactivated West Nile virus vaccine.
    Samina I; Havenga M; Koudstaal W; Khinich Y; Koldijk M; Malkinson M; Simanov M; Perl S; Gijsbers L; Weverling GJ; Uytdehaag F; Goudsmit J
    Vaccine; 2007 Nov; 25(49):8338-45. PubMed ID: 17977629
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Essential role of dengue virus envelope protein N glycosylation at asparagine-67 during viral propagation.
    Mondotte JA; Lozach PY; Amara A; Gamarnik AV
    J Virol; 2007 Jul; 81(13):7136-48. PubMed ID: 17459925
    [TBL] [Abstract][Full Text] [Related]  

  • 78. [Flavivirus encephalitis].
    Takasaki T
    Brain Nerve; 2009 Feb; 61(2):145-51. PubMed ID: 19235464
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Neuroblastoma cell-adapted yellow fever 17D virus: characterization of a viral variant associated with persistent infection and decreased virus spread.
    Vlaycheva LA; Chambers TJ
    J Virol; 2002 Jun; 76(12):6172-84. PubMed ID: 12021351
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Third-generation flavivirus vaccines based on single-cycle, encapsidation-defective viruses.
    Widman DG; Frolov I; Mason PW
    Adv Virus Res; 2008; 72():77-126. PubMed ID: 19081489
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.